Gsa Capital Partners LLP Aquestive Therapeutics, Inc. Transaction History
Gsa Capital Partners LLP
- $1.2 Billion
- Q3 2025
A detailed history of Gsa Capital Partners LLP transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 241,359 shares of AQST stock, worth $1.3 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
241,359
Previous 186,692
29.28%
Holding current value
$1.3 Million
Previous $618,000
118.28%
% of portfolio
0.11%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding AQST
# of Institutions
164Shares Held
65.9MCall Options Held
794KPut Options Held
457K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$52.9 Million100.0% of portfolio
-
Rtw Investments, LP New York, NY6.25MShares$33.7 Million0.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.66MShares$30.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$29.4 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.76MShares$20.3 Million0.05% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $288M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...